Kymera Therapeutics, Inc. (KYMR) dividend history
KYMRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/30227% above fair value
$121.52−4.33 (-3.44%)
Close on Nov 17, 2026Market cap $10.37BP/E –Yield –
Dividends
Kymera Therapeutics has not reported a dividend
No dividend per share appears in Kymera Therapeutics's annual filings since fiscal 2018.
See a number that looks wrong?